Home › Funds › Squadron Capital Management LLC › SLN
Squadron Capital Management LLC position in SLN
SILENCE THERAPEUTICS PLC · Health Care
Squadron Capital Management LLC reported holding 180,000 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.78% of its reported portfolio and ranking #32 among its reported holdings. Squadron Capital Management LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Squadron Capital Management LLC's SLN position evolved
Squadron Capital Management LLC first disclosed a stake in SLN in Q3 2026 at 180,000 shares (US$2.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 180.00K | $1.97M | New |
About SLN and 13F data
SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 45 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$31.6M), Redmile Group, LLC (US$26.9M), Soleus Capital Management, L.P. (US$26.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLN
- Siren, L.L.C. 2.89M sh · $31.56M · Q3 2026
- Redmile Group, LLC 2.46M sh · $26.90M · Q3 2026
- Soleus Capital Management, L.P. 2.39M sh · $26.08M · Q3 2026
- TCG Crossover Management, LLC 1.82M sh · $19.88M · Q3 2026
- Nextech Invest Ltd. 1.69M sh · $18.51M · Q3 2026
- KVP Capital Advisors, LP 684.12K sh · $7.48M · Q3 2026
- Tetragon Partners GP Ltd 500.00K sh · $5.46M · Q3 2026
- 5AM Venture Management, LLC 476.20K sh · $5.20M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 393.58K sh · $4.30M · Q3 2026
- Seven Fleet Capital Management LP 350.00K sh · $3.83M · Q3 2026
- Fortress Investment Group LLC 230.00K sh · $2.51M · Q3 2026
- Sofinnova Investments, Inc. 211.80K sh · $2.31M · Q3 2026
More on Squadron Capital Management LLC
FAQ
How long has Squadron Capital Management LLC held SLN?
Squadron Capital Management LLC has disclosed SLN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Squadron Capital Management LLC's current position in SLN?
As of Q3 2026, Squadron Capital Management LLC holds 180.00K shares of SLN (SILENCE THERAPEUTICS PLC), valued at $1.97M, representing 0.78% of its reported portfolio and ranking #32.
Has Squadron Capital Management LLC been buying or selling SLN?
In the latest 13F filing (Q3 2026), Squadron Capital Management LLC newly opened its position in SLN.
Which other funds hold SLN?
Other major institutional holders of SLN include Siren, L.L.C., Redmile Group, LLC, Soleus Capital Management, L.P., among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.